Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma.
Sivesh Kathir KamarajahSheraz Rehan MarkarDonald LowAlexander W PhillipsPublished in: BJS open (2023)
The extent of downstaging is an important prognosticator, whereas the optimal neoadjuvant therapy remains controversial. Identifying biomarkers associated with response to neoadjuvant regimens may permit individualized treatment.